3//SEC Filing
Sofinnova Partners SAS 3
Accession 0001209191-22-002283
CIK 0001868734other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 8:56 PM ET
Size
7.7 KB
Accession
0001209191-22-002283
Insider Transaction Report
Form 3
Sofinnova Partners SAS
10% Owner
Holdings
- (indirect: By Sofinnova Capital IX)
Series A Preferred Stock
→ Common Stock (2,941,176 underlying) - (indirect: By Sofinnova Capital IX)
Series B Preferred Stock
→ Common Stock (926,470 underlying)
Sofinnova Capital IX
10% Owner
Holdings
- (indirect: By Sofinnova Capital IX)
Series A Preferred Stock
→ Common Stock (2,941,176 underlying) - (indirect: By Sofinnova Capital IX)
Series B Preferred Stock
→ Common Stock (926,470 underlying)
Footnotes (2)
- [F1]Each share of Series A Preferred Stock and Series B Preferred Stock will automatically convert into shares of Common Stock on a 3.4:1 basis immediately prior to the closing of the Issuer's initial public offering and have no expiration date.
- [F2]The shares are directly held by Sofinnova Capital IX ("SC IX"). Sofinnova Partners SAS ("Sofinnova Partners") is the management company of SC IX and may be deemed to share voting and investment power over the shares held by SC IX. Sofinnova Partners disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein.
Documents
Issuer
CinCor Pharma, Inc.
CIK 0001868734
Entity typeother
IncorporatedFrance
Related Parties
1- filerCIK 0001574139
Filing Metadata
- Form type
- 3
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 8:56 PM ET
- Size
- 7.7 KB